Hsiri Therapeutics

Hsiri Therapeutics is a development-stage company dedicated to discovering and developing therapies for infections caused by drug-resistant bacteria. Hsiri's research focuses on two main areas – infections caused by mycobacteria and those caused by common bacterial pathogens. All research concepts for Hsiri Therapeutics products originate from the work of Professor Marvin Miller at the University of Notre Dame.